COVID-19

sales decline revenue decline sales revenue stock stock market
Pharma

WuXi Bio struggles amid CDMO industry downturn, stock plummets

A tough year for the biotech industry has taken a heavy toll on WuXi Biologics, sending the company’s stock plummeting nearly 24%.
Fraiser Kansteiner Dec 4, 2023 10:12am
Ken Paxton

Pfizer is the target of another lawsuit from Texas AG Paxton

Dec 1, 2023 11:11am
generic visual of COVID-19 vaccine booster shot

Pfizer sues Poland over alleged missed COVID-19 vaccine payments

Nov 28, 2023 12:02pm
Japanese flag

Daiichi Sankyo secures COVID vaccine supply pact in Japan

Nov 17, 2023 9:45am
layoffs job cuts workforce reduction layoff

Pfizer lays off hundreds of staffers in UK

Nov 14, 2023 10:40am
COVID story

Capturing COVID: Biopharma through the lens during the pandemic

Nov 13, 2023 7:45am
More News

Moderna tells health-conscious consumers to 'Spikevax that body'

Nov 9, 2023 8:55am

Pfizer gathers celebrities together for a crossover COVID ad

Nov 8, 2023 9:30am

BioNTech slashes 2023 revenue projection from €5B to €4B

Nov 6, 2023 11:49am

Catalent faces new possible 'cliff' after Sarepta miss: analyst

Nov 1, 2023 8:50am